Shanghai Runda Medical Technology Co (SHSE:603108) Piotroski F-Score: 4 (As of Aug. 01, 2026) — Near Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603108 Shanghai Runda Medical Technology Co Ltd SHSE:603108
39 GF Score
Price ¥10.01
GF Value ¥17.89
Valuation Possible Value Trap
! 8 Warning Signs
View Full Analysis

What is Shanghai Runda Medical Technology Co Piotroski F-Score?

Shanghai Runda Medical Technology Co SHSE:603108 +5.93% 39 Piotroski F-Score is 4 as of Aug. 01, 2026, which is at its 10-year median of 4.00. GuruFocus rates SHSE:603108 with a GF Score™ of 39/100 and a GF Value™ of ¥17.89 (Possible Value Trap). The stock has 8 warning signs investors should review. Among 207 Medical Diagnostics & Research companies, Shanghai Runda Medical Technology Co ranks worse than 53.14% on this metric.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Shanghai Runda Medical Technology Co has an F-score of 4 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Shanghai Runda Medical Technology Co's Piotroski F-Score or its related term are showing as below:

SHSE:603108' s Piotroski F-Score Range Over the Past 10 Years
Min: 1   Med: 4   Max: 8
Current: 4

During the past 13 years, the highest Piotroski F-Score of Shanghai Runda Medical Technology Co was 8. The lowest was 1. And the median was 4.

Shanghai Runda Medical Technology Co  (SHSE:603108) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Shanghai Runda Medical Technology Co Piotroski F-Score Related Terms


Shanghai Runda Medical Technology Co Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Shanghai Runda Medical Technology Co's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Runda Medical Technology Co Piotroski F-Score Chart

Shanghai Runda Medical Technology Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.00 4.00 5.00 5.00 3.00

Shanghai Runda Medical Technology Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.00 3.00 4.00 3.00 4.00

SHSE:603108 vs TMO, DHR, IDXX: Piotroski F-Score Comparison

For the Diagnostics & Research subindustry, Shanghai Runda Medical Technology Co's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Runda Medical Technology Co Piotroski F-Score vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Shanghai Runda Medical Technology Co's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Shanghai Runda Medical Technology Co's Piotroski F-Score falls into.


SHSE:603108
39GF Score
Shanghai Runda Medical Technology Co Ltd SHSE:603108
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Net Income was -51.393 + -42.039 + -385.702 + -53.561 = ¥-533 Mil.
Cash Flow from Operations was 37.127 + 285.148 + 198.278 + 46.179 = ¥567 Mil.
Revenue was 1808.642 + 1797.972 + 1730.07 + 1510.506 = ¥6,847 Mil.
Gross Profit was 381.384 + 406.934 + 363.263 + 351.074 = ¥1,503 Mil.
Average Total Assets from the begining of this year (Mar25)
to the end of this year (Mar26) was
(14039.402 + 13788.587 + 13916.2 + 13417.761 + 13093.374) / 5 = ¥13651.0648 Mil.
Total Assets at the begining of this year (Mar25) was ¥14,039 Mil.
Long-Term Debt & Capital Lease Obligation was ¥590 Mil.
Total Current Assets was ¥8,165 Mil.
Total Current Liabilities was ¥7,547 Mil.
Net Income was 68.702 + -40.881 + 4.856 + -69.259 = ¥-37 Mil.

Revenue was 2062.79 + 2041.018 + 2135.494 + 1661.846 = ¥7,901 Mil.
Gross Profit was 565.261 + 462.789 + 524.849 + 345.32 = ¥1,898 Mil.
Average Total Assets from the begining of last year (Mar24)
to the end of last year (Mar25) was
(14405.956 + 14497.797 + 14361.165 + 14305.543 + 14039.402) / 5 = ¥14321.9726 Mil.
Total Assets at the begining of last year (Mar24) was ¥14,406 Mil.
Long-Term Debt & Capital Lease Obligation was ¥1,109 Mil.
Total Current Assets was ¥8,945 Mil.
Total Current Liabilities was ¥7,294 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Shanghai Runda Medical Technology Co's current Net Income (TTM) was -533. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Shanghai Runda Medical Technology Co's current Cash Flow from Operations (TTM) was 567. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar25)
=-532.695/14039.402
=-0.03794286

ROA (Last Year)=Net Income/Total Assets (Mar24)
=-36.582/14405.956
=-0.00253937

Shanghai Runda Medical Technology Co's return on assets of this year was -0.03794286. Shanghai Runda Medical Technology Co's return on assets of last year was -0.00253937. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Shanghai Runda Medical Technology Co's current Net Income (TTM) was -533. Shanghai Runda Medical Technology Co's current Cash Flow from Operations (TTM) was 567. ==> 567 > -533 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar26)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar25 to Mar26
=589.752/13651.0648
=0.0432019

Gearing (Last Year: Mar25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar24 to Mar25
=1109.243/14321.9726
=0.07745043

Shanghai Runda Medical Technology Co's gearing of this year was 0.0432019. Shanghai Runda Medical Technology Co's gearing of last year was 0.07745043. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar26)=Total Current Assets/Total Current Liabilities
=8165.274/7547.35
=1.08187298

Current Ratio (Last Year: Mar25)=Total Current Assets/Total Current Liabilities
=8944.695/7293.69
=1.22636073

Shanghai Runda Medical Technology Co's current ratio of this year was 1.08187298. Shanghai Runda Medical Technology Co's current ratio of last year was 1.22636073. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Shanghai Runda Medical Technology Co's number of shares in issue this year was 595.125. Shanghai Runda Medical Technology Co's number of shares in issue last year was 629.625. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=1502.655/6847.19
=0.21945572

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=1898.219/7901.148
=0.24024597

Shanghai Runda Medical Technology Co's gross margin of this year was 0.21945572. Shanghai Runda Medical Technology Co's gross margin of last year was 0.24024597. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar25)
=6847.19/14039.402
=0.48771237

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar24)
=7901.148/14405.956
=0.54846398

Shanghai Runda Medical Technology Co's asset turnover of this year was 0.48771237. Shanghai Runda Medical Technology Co's asset turnover of last year was 0.54846398. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+1+0+1+1+0+1+0+0
=4

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Shanghai Runda Medical Technology Co has an F-score of 4 indicating the company's financial situation is typical for a stable company.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 4 mean?
Shanghai Runda Medical Technology Co (SHSE:603108) has a Piotroski F-Score of 4 as of Aug. 01, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Shanghai Runda Medical Technology Co and its competitors. This is near median its historical median of 4.00. Over the past decade, Shanghai Runda Medical Technology Co's Piotroski F-Score has ranged from 1.00 to 8.00. According to the industry distribution chart, Shanghai Runda Medical Technology Co ranks #110 out of 207 companies in the Medical Diagnostics & Research industry, placing it in the top 53.1%.
Is Shanghai Runda Medical Technology Co's Piotroski F-Score too high?
Shanghai Runda Medical Technology Co's current Piotroski F-Score of 4 is near median its 10-year median of 4.00. Over the past 10 years, this metric has ranged from a low of 1.00 to a high of 8.00. The Medical Diagnostics & Research industry median Piotroski F-Score is 5.00. Shanghai Runda Medical Technology Co's value of 4 is 20% below this industry median. Based on the distribution chart, Shanghai Runda Medical Technology Co ranks #110 out of 207 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint. Overall, Shanghai Runda Medical Technology Co has a GF Score™ of 39/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Shanghai Runda Medical Technology Co's Piotroski F-Score compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Shanghai Runda Medical Technology Co ranks #110 out of 207 companies for Piotroski F-Score. This places Shanghai Runda Medical Technology Co in the lower half of its industry. The industry median Piotroski F-Score is 5.00. Shanghai Runda Medical Technology Co's value of 4 is 20% below this benchmark. Historically, Shanghai Runda Medical Technology Co's own Piotroski F-Score has ranged from 1.00 to 8.00 over the past decade. While the company's 10-year median is 4.00 vs. the industry median of 5.00, Shanghai Runda Medical Technology Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Medical Diagnostics & Research company?
The median Piotroski F-Score among Medical Diagnostics & Research companies is 5.00, based on 207 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghai Runda Medical Technology Co's current Piotroski F-Score of 4 is 20% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Shanghai Runda Medical Technology Co and its competitors. For the Medical Diagnostics & Research industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai Runda Medical Technology Co's current Piotroski F-Score is 4, which is near median its own 10-year median of 4.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Runda Medical Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Runda Medical Technology Co (SHSE:603108) is currently considered Possible Value Trap. The stock's GF Value™ is ¥17.89, compared to a current price of ¥10.01 — trading 44% below its estimated fair value. The current Piotroski F-Score is 4, which is near median its 10-year median of 4.00 and 20% below the Medical Diagnostics & Research industry median of 5.00. Shanghai Runda Medical Technology Co's overall GF Score™ is 39/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Shanghai Runda Medical Technology Co (SHSE:603108), the current Piotroski F-Score is 4 as of Aug. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shanghai Runda Medical Technology Co (SHSE:603108) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai Runda Medical Technology Co stock appears to be undervalued. The current stock price of ¥10.01 is trading 44% below its estimated GF Value™ of ¥17.89. GuruFocus considers Shanghai Runda Medical Technology Co to be Possible Value Trap.

Key valuation signals for SHSE:603108:

  • Piotroski F-Score: 4 (near median its 10-year median of 4.00)
  • GF Value™: ¥17.89 vs. price of ¥10.01 (44% below fair value)
  • GF Score™: 39/100 with 8 warning signs
  • Industry Position: 20% below the Medical Diagnostics & Research median (#110 of 207)

No single metric tells the full story. See the SHSE:603108 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shanghai Runda Medical Technology Co Business Description

Address Orient International Science & Technology Mansion, Room D-I, 15th Floor, 58 Xiangcheng Road, Pudong District, Shanghai, CHN, 200122
Shanghai Runda Medical Technology Co Ltd is a medical laboratory integrated service provider based in East China. The company provides in-vitro diagnostic products and professional technical support to various medical laboratories.
39GF Score

Get the complete analysis for SHSE:603108

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥10.01
Price
¥17.89
GF Value